Kerry Blanchard is the CEO of Everest Medicines, a Chinese biopharmaceutical company.
Kerry Blanchard is the CEO of Everest Medicines, a Chinese biopharmaceutical company. He assumed the position in February 2020. Prior to this, he served as the CSO of Innovent Biologics, and spent 17 years at Eli Lilly, where he worked on developing medicines, including abemaciclib.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide